The global GLP-1 analogues market size was assessed at USD 46.70 billion in 2024. The market is expected to flourish and grow from USD 56.62 billion in 2025 to USD 322.85 billion by 2034, denoting a ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
Hosted on MSN1d
Ozempic and Viagra, among the more than 80 drugs expected to work against Alzheimer's in the coming yearsThere are also oral medications in phase III based on a possible action against tau, such as simufilam and ...
What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which play a major role in your weight and weight loss, says Dr. Russo. These ...
Doctors Without Borders (MSF) and organisations representing people with diabetes picketed outside the offices of insulin ...
Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...
Of 200 countries studied by experts by the World Health Organization, in the period between 1990 and 2022 - the most recent ...
About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...
Of 200 countries studied by experts by the World Health Organization, in the period between 1990 and 2022 - the most recent ...
From bespoke boob jobs and “luxury” dentists to award-winning skincare lines, here are the big names in eastern suburbs ...
When Sara first arrived at her rescuers’ home, she was sick, tired, and was covered in ringworms and signs of abuse all over ...
Sacking is too good for the 30 bishops who are being forced out of the Church of England over the revolting John Smyth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback